GlassScriptPhysician profile
Michelle Kirschbaum Martin
NPI 1164615985
$3,311.71
in general payments reported to CMS, 2019-2025
36 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $946 · 2022: $686 · 2023: $833 · 2024: $509 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,678.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,203.00 | 2021-2025 | |
| Novo Nordisk INC | $576.07 | 2021-2025 | Rybelsus, Ozempic |
| Zimmer Biomet Holdings, INC. | $258.45 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $134.18 | 2023-2025 | |
| Glaxosmithkline, LLC. | $82.96 | 2022-2023 | Shingrix, Trelegy Ellipta, Bexsero |
| Astrazeneca Pharmaceuticals LP | $71.81 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $71.49 | 2022 | |
| Pfizer INC. | $61.33 | 2023-2024 | |
| Lundbeck LLC | $60.07 | 2023 | Rexulti |
| Astellas Pharma US INC | $52.05 | 2023-2025 | Veozah, Myrbetriq |
| Gilead Sciences, INC. | $49.32 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $46.69 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $44.55 | 2022-2023 | Contrave, Nexlizet, Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $42.83 | 2021-2022 | |
| Abiomed | $40.06 | 2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $37.29 | 2021 | |
| Corium, LLC | $37.15 | 2023 | Azstarys |
| Idorsia Pharmaceuticals US INC | $34.82 | 2023 | Quviviq |
| Edwards Lifesciences Corporation | $34.18 | 2022 | |
| Viiv Healthcare Company | $34.01 | 2025 | Dovato |
| Boston Scientific Corporation | $32.54 | 2025 | Varithena Administration Pack |
| Myovant Sciences INC. | $31.74 | 2022 | |
| Nestle Healthcare Nutrition INC. | $28.37 | 2022 | |
| Sanofi-Aventis U.S. LLC | $26.91 | 2025 | |
| Horizon Therapeutics Plc | $21.29 | 2023 | Krystexxa |
| Ibsa Pharma INC. | $21.23 | 2025 | Flector, Tirosint, Licart |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.59 | 2024 | Caplyta |
| Exeltis, USA INC. | $20.48 | 2024 | Slynd |
| Sunovion Pharmaceuticals INC. | $19.62 | 2022 | |
| Inspire Medical Systems, INC. | $19.44 | 2024 | Inspire |
| Si-Bone, INC. | $19.35 | 2025 | |
| Hologic Sales and Service, LLC | $17.76 | 2024 | Aptima, Thinprep 2000 Processor |
| Dexcom, INC. | $16.66 | 2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $16.52 | 2021 | |
| Antares Pharma, INC. | $13.56 | 2021 | |
| Nevro Corp. | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.